DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Evista (Raloxifene) - Adverse Event Reports - Life Threatening Events

 



Index of reports > Cases resulting in life threatening events (8)

     Endometrial Cancer (2)Haemorrhage (1)Pain (1)Drug Interaction (1)Amnesia (1)International Normalised Ratio Fluctuation (1)Prothrombin Time Abnormal (1)Carotid Artery Disease (1)Feeling Abnormal (1)Acute Myocardial Infarction (1)

Below is the selection of adverse event reports related to Evista (Raloxifene) that includes cases resulting in life threatening events.

Adverse event in 50 year old female receiving Evista (Raloxifene)

Reported by a consumer/non-health professional from United States on 2007-10-05

Patient: 50 year old female, weighing 72.6 kg (159.7 pounds)

Adverse reactions / side effects: Prothrombin Time Abnormal, Haemorrhage, Pain, Feeling Abnormal, International Normalised Ratio Fluctuation, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Evista (Raloxifene)



Adverse event in 74 year old female receiving Evista (Raloxifene)

Reported by a physician from Japan on 2007-07-19

Patient: 74 year old female, weighing 54.0 kg (118.8 pounds)

Adverse reactions / side effects: Venous Thrombosis

Adverse event resulted in: life threatening event

Suspect drug(s):
Rocaltrol
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2004-11-02

Evista
    Administration route: Oral
    Indication: Osteoporosis
    Start date: 2005-01-27
    End date: 2007-06-14

Other drugs received by patient: Famotidine; Myslee; Amlodipine



Adverse event in 74 year old female receiving Evista (Raloxifene)

Reported by a physician from Japan on 2007-07-03

Patient: 74 year old female

Adverse reactions / side effects: Embolism Venous

Adverse event resulted in: life threatening event

Suspect drug(s):
Rocaltrol
    Administration route: Oral
    Indication: Osteoporosis Postmenopausal

Evista
    Administration route: Oral
    Indication: Osteoporosis Postmenopausal
    Start date: 2005-01-27
    End date: 2007-06-14

Gaster

Zolpidem
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication



Adverse event in 59 year old female receiving Evista (Raloxifene)

Reported by a physician from Japan on 2007-05-08

Patient: 59 year old female, weighing 53.0 kg (116.6 pounds)

Adverse reactions / side effects: Acute Myocardial Infarction

Adverse event resulted in: life threatening event

Suspect drug(s):
Evista (Raloxifene)

Other drugs received by patient: Pravastatin Sodium; Norvasc; Thyradin S



Adverse event in 72 year old female receiving Evista (Raloxifene)

Reported by a physician from Japan on 2007-04-18

Patient: 72 year old female

Adverse reactions / side effects: Anti-Neutrophil Cytoplasmic Antibody Positive Vasculitis

Adverse event resulted in: life threatening event

Suspect drug(s):
Evista (Raloxifene)



Adverse event in 56 year old female receiving Evista (Raloxifene)

Reported by a physician from Croatia (Local Name: Hrvatska) on 2007-03-08

Patient: 56 year old female

Adverse reactions / side effects: Endometrial Cancer, Drug Interaction

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Evista (Raloxifene)

Other drugs received by patient possibly interacting with the suspect drug:
Activelle
    Dosage: unk, unknown
    Indication: Menopause
    Start date: 2004-12-01
    End date: 2006-10-01



Adverse event in 56 year old female receiving Evista (Raloxifene)

Reported by a physician from Croatia (Local Name: Hrvatska) on 2007-03-06

Patient: 56 year old female

Adverse reactions / side effects: Endometrial Cancer

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Evista (Raloxifene)

Other drugs received by patient: Activelle



Adverse event in 60 year old female receiving Evista (Raloxifene)

Reported by a physician from United States on 2007-02-05

Patient: 60 year old female, weighing 60.8 kg (133.7 pounds)

Adverse reactions / side effects: Road Traffic Accident, Traumatic Brain Injury, Carotid Artery Disease, Amnesia, Loss of Consciousness

Adverse event resulted in: life threatening event, hospitalization, disablity

Suspect drug(s):
Evista
    Dosage: 60 mg, daily (1/d)
    Indication: Osteoporosis

Evista
    Dosage: 60 mg, daily (1/d)
    Start date: 2003-01-01

Other drugs received by patient: Zoloft; Lipitor; Vitamins NOS; Vesicare

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009